Predictive role of nutritional and immune-inflammatory indexes in the diagnostic work-up and risk stratification of heart failure with preserved ejection fraction
Authors:
- 1 April 2026
- journal article
- Published by Edizioni Minerva Medica in Minerva Cardiology and Angiology
- Vol. 74 (2)
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a significant public health concern with high morbidity. This study evaluates the prognostic significance of Prognostic Nutritional Index (PNI) and Pan-Immune-Inflammation Value (PIV) in HFpEF, aiming to enhance understanding of its inflammatory and nutritional aspects and identify markers for better diagnosis and risk stratification. This retrospective cohort study included 71 patients diagnosed with HFpEF using the HFA-PEFF algorithm and 81 control subjects without heart failure. The PIV, and PNI indices were calculated. A 6-month follow-up of the HFpEF group was conducted to assess rehospitalization rates. The study found that patients with HFpEF had significantly higher PIV and PNI rates than the control group (P=0.016, P<0.001). A negative correlation (r=-0.328, P<0.001) was observed between the PNI and HFA-PEFF scores. The ROC analysis demonstrated that PIV (AUC: 0.92) had the strongest predictive ability for rehospitalization, followed by Systemic Immune-Inflammatory Index (SII, AUC: 0.87) and PNI (AUC: 0.78), while BMI showed the weakest performance (AUC: 0.59). The multivariate logistic regression analysis demonstrated that both PNI (OR: 0.783, 95% CI: 0.627-0.977, P=0.031) and PIV (OR: 1.012, 95% CI: 1.003-1.021, P=0.008) were significant predictors of rehospitalization in HFpEF patients. PIV and PNI are important parameters that play a predictive role in diagnosing HFpEF and independently predicting rehospitalization. In the multivariate analyses for rehospitalization, that PIV stands out more than SII, and PNI stands out more than BMI, was current and valuable information.Keywords
This publication has 24 references indexed in Scilit:
- Malnutrition in heart failure with preserved ejection fractionJournal of the American Geriatrics Society, 2023
- The association of hemodynamic markers of right ventricular dysfunction with SII index and clinical outcomes in reduced ejection fraction heart failureMedicine, 2023
- The prognostic impact of inflammation in patients with decompensated acute heart failure, as assessed using the pan-immune inflammation value (PIV)Scandinavian Journal of Clinical and Laboratory Investigation, 2023
- Reappraising the role of chronic inflammatory burden in heart failureThe Journal of Gene Medicine, 2023
- Comparison of pan‐immune‐inflammation value with other inflammation markers of long‐term survival afterST‐segment elevation myocardial infarctionEuropean Journal of Clinical Investigation, 2022
- Heart Failure With Reduced Ejection FractionJAMA, 2020
- Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery diseaseEuropean Journal of Clinical Investigation, 2020
- H2FPEF score predicts 1-year rehospitalisation of patients with heart failure with preserved ejection fractionPostgraduate Medical Journal, 2020
- How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)European Heart Journal, 2019
- Exaggerated Inflammation and Monocytosis Associate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction: Evidence of M2 Macrophage Activation in Disease PathogenesisJournal of Cardiac Failure, 2015